Sidoti Equities Analysts Lower Earnings Estimates for PRE

Prenetics Global Limited (NASDAQ:PRE – Free Report) – Analysts at Sidoti cut their Q3 2028 earnings per share estimates for Prenetics Global in a note issued to investors on Thursday, November 19th. Sidoti analyst A. Hantman now anticipates that the company will post earnings of $0.52 per share for the quarter, down from their previous estimate of $0.60. The consensus estimate for Prenetics Global’s current full-year earnings is ($2.36) per share.

A number of other equities research analysts also recently issued reports on PRE. Maxim Group assumed coverage on shares of Prenetics Global in a research note on Monday, October 26th. They set a “buy” rating and a $41.00 price objective on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Prenetics Global in a report on Thursday, October 15th. Lucid Cap Mkts upgraded shares of Prenetics Global to a “strong-buy” rating in a research report on Monday, October 12th. B. Riley Financial dropped their target price on shares of Prenetics Global from $37.00 to $31.00 and set a “buy” rating for the company in a research report on Thursday. Finally, Craig Hallum started coverage on shares of Prenetics Global in a report on Thursday, September 17th. They set a “buy” rating and a $40.00 price target for the company. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $36.17.

Get Our Latest Stock Report on Prenetics Global

Prenetics Global Stock Down 0.4%

PRE stock opened at $10.31 on Friday. The company has a market cap of $173.93 million, a PE ratio of -2.03 and a beta of 0.40. The business has a 50-day simple moving average of $19.53 and a 200 day simple moving average of $19.44. Prenetics Global has a 52 week low of $9.13 and a 52 week high of $27.24.

Prenetics Global (NASDAQ:PRE – Get Free Report) last released its earnings results on Sunday, November 1st. The company reported ($1.45) earnings per share (EPS) for the quarter. Prenetics Global had a negative return on equity of 31.73% and a negative net margin of 46.76%. The company had revenue of $64.11 million for the quarter.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. State of Wyoming bought a new stake in shares of Prenetics Global during the first quarter worth about $48,000. Operose Advisors LLC acquired a new position in shares of Prenetics Global in the second quarter valued at approximately $129,000. Virtu Financial LLC bought a new position in Prenetics Global in the 3rd quarter valued at approximately $252,000. Goldman Sachs Group Inc. bought a new position in Prenetics Global in the 3rd quarter valued at approximately $253,000. Finally, State Street Corp bought a new position in Prenetics Global in the 3rd quarter valued at approximately $264,000. 25.01% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, CEO Danny Sheng Wu Yeung bought 17,181 shares of the business’s stock in a transaction on Monday, August 24th. The shares were purchased at an average price of $21.23 per share, for a total transaction of $364,752.63. Following the completion of the transaction, the chief executive officer directly owned 112,416 shares of the company’s stock, valued at approximately $2,386,591.68. This represents a 18.04% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Brian J. Rosin bought 18,000 shares of the business’s stock in a transaction on Monday, August 24th. The stock was bought at an average price of $21.19 per share, for a total transaction of $381,420.00. Following the transaction, the chief financial officer directly owned 18,000 shares of the company’s stock, valued at approximately $381,420. This represents a ? increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last quarter, insiders have purchased 40,281 shares of company stock valued at $862,453. 7.80% of the stock is owned by corporate insiders.

Latest Prenetics Global News

These are some of the PRE news items that stood out recently:

  • Positive Sentiment: Third-quarter revenue rose about 228% year over year to $64.1 million, topping both company guidance and analyst estimates. IM8 revenue grew 266% to $62.9 million, its seventh consecutive record quarter. Prenetics reaffirmed its 2026 revenue outlook of $220–230 million and forecast IM8 revenue of more than $400 million in 2027. Prenetics third-quarter results and guidance
  • Positive Sentiment: The company reported $4.1 million in positive adjusted free cash flow and improved its adjusted EBITDA loss as a percentage of revenue versus the prior quarter, while cash and current financial assets stood at $111.5 million at quarter-end. Prenetics third-quarter results
  • Negative Sentiment: Prenetics’ quarterly loss was wider than expected: EPS was negative $0.93 versus analyst expectations of negative $0.90. More significantly, it raised its expected second-half 2026 adjusted EBITDA loss to $30–35 million from its prior $8–12 million outlook, reflecting increased customer-acquisition investment. This profitability outlook helps explain recent share weakness. Prenetics shares fall on wider loss and lower second-half guidance

Prenetics Global Company Profile

(Get Free Report)

Prenetics Global Limited is a health sciences company focused on consumer wellness and health-related products. Its portfolio includes IM8, a consumer wellness brand offering nutritional supplements, and CircleDNA, a genetic testing service that provides reports on health, wellness and ancestry. The company has also operated clinical genomic testing services and provided COVID-19 testing during the pandemic. Its business has since shifted toward consumer health and wellness. Prenetics was founded in 2014 and is led by co-founder and Chief Executive Officer Danny Yeung.

Featured Stories

Earnings History and Estimates for Prenetics Global (NASDAQ:PRE)

Receive News & Ratings for Prenetics Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prenetics Global and related companies with MarketBeat.com's FREE daily email newsletter.